Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Care Surgery Service Is Essential During a Nonsurgical Catastrophic Event, the COVID-19 Pandemic.

The American surgeonยท2020
Same author

Fifteen-minute Frequency of Glucose Measurements and the Use of Threshold Alarms: Impact on Mitigating Dysglycemia in Critically Ill Patients.

Journal of diabetes science and technologyยท2019
Same author

Prospective Observational Study Comparing Sepsis-2 and Sepsis-3 Definitions in Predicting Mortality in Critically Ill Patients.

Open forum infectious diseasesยท2019
Same author

Glucose Control, Diabetes Status, and Mortality in Critically Ill Patients: The Continuum From Intensive Care Unit Admission to Hospital Discharge.

Mayo Clinic proceedingsยท2017
Same author

Round Table Discussion on Inpatient Use of Continuous Glucose Monitoring at the International Hospital Diabetes Meeting.

Journal of diabetes science and technologyยท2016
Same author

Physician report cards and rankings yield long-lasting hand hygiene compliance exceeding 90%.

Critical care (London, England)ยท2015
Same journal

Case law update.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Managementยท2026
Same journal

Mitigating risk in audiology and speech therapy practice: Essential risk management and control strategies for private and public practices in resource-constrained health systems.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Managementยท2026
Same journal

Predictors and contributors of burnout among hospitalists in central Michigan.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Managementยท2026
Same journal

Gaslighting in the context of diagnostic safety: A concept analysis.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Managementยท2026
Same journal

Promoting reflective learning in medication safety education.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Managementยท2026
Same journal

Knowledge, attitudes, and practices of healthcare professionals toward near-miss reporting.

Journal of healthcare risk management : the journal of the American Society for Healthcare Risk Managementยท2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Avoiding pitfalls of anticoagulation therapy.

Stanley A Nasraway1

  • 1Surgical Intensive Care Units, Tufts-New England Medical Center and Surgery, Medicine & Anesthesia, Boston, USA.

Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management
|March 5, 2010
PubMed
Summary
This summary is machine-generated.

Antithrombotic therapy, while crucial, carries litigation risks due to potential adverse events. This article shows how evidence-based guidelines, documentation, and communication can minimize errors in antithrombotic treatment.

More Related Videos

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

Related Experiment Videos

Last Updated: Jun 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

Area of Science:

  • Medical Litigation
  • Patient Safety
  • Pharmacology

Background:

  • Antithrombotic therapy is essential for managing thrombotic conditions.
  • This therapy carries inherent risks of bleeding and thrombosis.
  • Adverse outcomes from antithrombotic therapy can lead to significant litigation.

Purpose of the Study:

  • To explore strategies for reducing litigation risk in antithrombotic therapy.
  • To illustrate the application of evidence-based practices in managing antithrombotic therapy.
  • To highlight the role of documentation and communication in patient safety.

Main Methods:

  • A case-based approach was utilized.
  • Review of evidence-based guidelines for antithrombotic therapy.
  • Analysis of documentation practices.
  • Examination of patient communication strategies.

Main Results:

  • Evidence-based guidelines provide a framework for safe antithrombotic prescribing.
  • Thorough documentation is crucial for risk management and defense.
  • Effective patient communication enhances adherence and reduces misunderstandings.
  • Implementing these strategies can mitigate errors and potential litigation.

Conclusions:

  • Adherence to evidence-based guidelines, meticulous documentation, and clear patient communication are vital.
  • These elements collectively contribute to reducing errors and litigation risk in antithrombotic therapy.
  • Proactive risk management is essential for healthcare providers administering antithrombotic treatments.